You are here

  • Home
  • Archive
  • Volume 56, Issue 7
  • Enhanced jejunal production of antibodies to Klebsiella and other Enterobacteria in patients with ankylosing spondylitis and rheumatoid arthritis

Article Text

Article menu
Download PDFPDF
Extended reports
Enhanced jejunal production of antibodies to Klebsiella and other Enterobacteria in patients with ankylosing spondylitis and rheumatoid arthritis
  1. Outi Mäki-Ikolaa,
  2. Roger Hällgrenb,
  3. Lars Kanerudc,
  4. Nils Felteliusb,
  5. Lars Knutssond,
  6. Kaisa Granforsa
  1. aNational Public Health Institute, Department in Turku, Turku, Finland , bUniversity Hospital, Department of Internal Medicine, Section of Rheumatology, Uppsala, Sweden , cKarolinska Institute, Stockholm Söder Hospital, Department of Rheumatology, Stockholm, Sweden , dUniversity Hospital, Department of Surgery, Uppsala, Sweden
  1. Dr O Mäki-Ikola, National Public Health Institute, Department in Turku, Kiinamyllynkatu 13, SF-20520 Turku, Finland.

Abstract

OBJECTIVE To measure gut immunity directly in jejunal fluid in patients with ankylosing spondylitis (AS) and rheumatoid arthritis (RA).

METHODS Antibodies against three different Enterobacterias were measured in jejunal perfusion fluids (collected by a double balloon perfusion device) of 19 patients with AS, 14 patients with RA, and 22 healthy controls using enzyme linked immunosorbent assay.

RESULTS The AS patients had significantly increased jejunal fluid concentrations of IgM, IgG, and IgA class antibodies against Klebsiella pneumoniae, and IgM and IgA class antibodies against Escherichia coli and Proteus mirabilis compared with healthy controls. When compared with the patients with RA, the AS patients had higher concentrations of IgA and IgG class antibodies only against K pneumoniae. The RA patients had higher IgM class antibody concentrations against all three studied Enterobacterias, when compared with the healthy controls, suggesting an enhanced mucosal immune response in these patients. A three month treatment with sulphasalazine did not decrease enterobacterial antibody concentrations in the 10 patients with AS.

CONCLUSION There is strong direct evidence for an abnormal mucosal humoral immune response particularly to K pneumoniae in patients with AS.

  • ankylosing spondylitis
  • antibody
  • Enterobacteria
  • enzyme linked immunosorbent assay

https://doi.org/10.1136/ard.56.7.421

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text